ERBB2 and breast carcinoma: Understanding and addressing geography-related variability in referral pathways and NAC for TN and HER2+ breast cancer—for which local referral pathways, clinician knowledge and practice patterns, and resource availability may be underlying mechanisms—should be prioritized to improve the design of cancer systems.